Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-250800
Filing Date
2024-11-04
Accepted
2024-11-04 19:59:58
Documents
2
Group Members
ACCESS INDUSTRIES HOLDINGS LLCAI BIOTECHNOLOGY LLCLEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d899713dsc13ga.htm SC 13G/A 86573
2 EX-99.1 d899713dex991.htm EX-99.1 8224
  Complete submission text file 0001193125-24-250800.txt   96579
Mailing Address 730 FIFTH AVENUE NEW YORK NY 10019
Business Address 730 FIFTH AVENUE NEW YORK NY 10019 2122476400
ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by) CIK: 0001508226 (see all company filings)

EIN.: 133970710 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Subject) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94122 | Film No.: 241425246
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)